UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication

Scientific reports, 2017-07, Vol.7 (1), p.6345-11, Article 6345

2017

Volltextzugriff (PDF)

Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors

Journal of antimicrobial chemotherapy, 2017-03, Vol.72 (3), p.727-734

2017

Volltextzugriff (PDF)

Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.600-608

2016

Volltextzugriff (PDF)

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.3100-3109

2013

Volltextzugriff (PDF)

The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration

mBio, 2017-04, Vol.8 (2)

2017

Volltextzugriff (PDF)

Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1

Scientific reports, 2019-11, Vol.9 (1), p.17620-17620, Article 17620

2019

Volltextzugriff (PDF)

Publisher Correction: Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1

Scientific reports, 2020-02, Vol.10 (1), p.3337-3337, Article 3337

2020

Volltextzugriff (PDF)

Erratum for Mesplède et al., "The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration"

mBio, 2018-09, Vol.9 (5)

2018

Volltextzugriff (PDF)

Comparative Neuroprotective Properties of Stilbene and Catechin Analogs: Action Via a Plasma Membrane Receptor Site?

CNS neuroscience & therapeutics, 2009-03, Vol.15 (1), p.76-83

2009

Volltextzugriff (PDF)

The Connection Domain Mutation N348I in HIV-1 Reverse Transcriptase Enhances Resistance to Etravirine and Rilpivirine but Restricts the Emergence of the E138K Resistance Mutation by Diminishing Viral Replication Capacity

Journal of Virology, 2014-02, Vol.88 (3), p.1536-1547

2014

Volltextzugriff (PDF)

Molecular Mechanism of Antagonism between the Y181C and E138K Mutations in HIV-1 Reverse Transcriptase

Journal of Virology, 2012-12, Vol.86 (23), p.12983-12990

2012

Volltextzugriff (PDF)

Role of the K101E Substitution in HIV-1 Reverse Transcriptase in Resistance to Rilpivirine and Other Nonnucleoside Reverse Transcriptase Inhibitors

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5649-5657

2013

Volltextzugriff (PDF)

Subunit-Selective Mutational Analysis and Tissue Culture Evaluations of the Interactions of the E138K and M184I Mutations in HIV-1 Reverse Transcriptase

Journal of Virology, 2012-08, Vol.86 (16), p.8422-8431

2012

Volltextzugriff (PDF)

Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update

Expert opinion on investigational drugs, 2018-12, Vol.27 (12), p.951-962

2018

Volltextzugriff (PDF)

Antimalarial drugs and their metabolites are potent Zika virus inhibitors

Journal of medical virology, 2019-07, Vol.91 (7), p.1182-1190

2019

Volltextzugriff (PDF)

The antimalarial drug amodiaquine possesses anti‐ZIKA virus activities

Journal of medical virology, 2018-05, Vol.90 (5), p.796-802

2018

Volltextzugriff (PDF)

Late Indosinian granitoids in the Zhacanggou, Guide Basin, NW China: Whole‐rock geochemistry, zircon U–Pb geochronology, Lu–Hf isotopes, and implications for magma mixing

Geological journal (Chichester, England), 2022-04, Vol.57 (4), p.1584-1599

2022

Volltextzugriff (PDF)

JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1

Journal of virology, 2017-05, Vol.91 (9)

2017

Volltextzugriff (PDF)

Investigational HIV integrase inhibitors in phase I and phase II clinical trials

Expert opinion on investigational drugs, 2017-11, Vol.26 (11), p.1207-1213

2017

Volltextzugriff (PDF)

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness

Retrovirology, 2014-01, Vol.11 (1), p.7-7, Article 7

2014

Volltextzugriff (PDF)

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure

Retrovirology, 2013-02, Vol.10 (1), p.22-22, Article 22

2013

Volltextzugriff (PDF)

P-I1 Monotherapy with integrase inhibitors does not maintain viral suppression in humanized mice with chronic HIV infection

Journal of acquired immune deficiency syndromes (1999), 2018-04, Vol.77 (1), p.64-64

2018

Volltextzugriff (PDF)

The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors

The Journal of infectious diseases, 2018-07, Vol.218 (5), p.698-706

2018

Volltextzugriff (PDF)

Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity

Journal of antimicrobial chemotherapy, 2014-10, Vol.69 (10), p.2733-2740

2014

Volltextzugriff (PDF)

Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice

Journal of antimicrobial chemotherapy, 2017-09, Vol.72 (9), p.2570-2573

2017

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(96)
Tagungsberichte
(1)

Sprache

Englisch
(97)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication

Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors

Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine

The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration

Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1

Publisher Correction: Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1

Erratum for Mesplède et al., "The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration"

Comparative Neuroprotective Properties of Stilbene and Catechin Analogs: Action Via a Plasma Membrane Receptor Site?

The Connection Domain Mutation N348I in HIV-1 Reverse Transcriptase Enhances Resistance to Etravirine and Rilpivirine but Restricts the Emergence of the E138K Resistance Mutation by Diminishing Viral Replication Capacity

Molecular Mechanism of Antagonism between the Y181C and E138K Mutations in HIV-1 Reverse Transcriptase

Role of the K101E Substitution in HIV-1 Reverse Transcriptase in Resistance to Rilpivirine and Other Nonnucleoside Reverse Transcriptase Inhibitors

Subunit-Selective Mutational Analysis and Tissue Culture Evaluations of the Interactions of the E138K and M184I Mutations in HIV-1 Reverse Transcriptase

Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update

Antimalarial drugs and their metabolites are potent Zika virus inhibitors

The antimalarial drug amodiaquine possesses anti‐ZIKA virus activities

Late Indosinian granitoids in the Zhacanggou, Guide Basin, NW China: Whole‐rock geochemistry, zircon U–Pb geochronology, Lu–Hf isotopes, and implications for magma mixing

JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope-Mutated HIV-1

Investigational HIV integrase inhibitors in phase I and phase II clinical trials

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure

P-I1 Monotherapy with integrase inhibitors does not maintain viral suppression in humanized mice with chronic HIV infection

The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors

Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity

Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice

Suchergebnisse filtern